Vemurafenib
#
Find similar titles
- (rev. 2)
- Hyungyong Kim
x
Redirected from Zelboraf
Structured data
- Image
- URL
- http://en.wikipedia.org/wiki/Vemurafenib
Vemurafenib (INN, marketed as Zelboraf) is a BRAF enzyme inhibitor developed by Plexxikon (now part of the Daiichi Sankyo group) and Genentech for the treatment of late-stage Melanoma.
Incoming Links #
Related Articles (Article 0) #
Related Drugs (Drug 1) #
Suggested Pages #
- 0.293 Nivolumab
- 0.160 Lung cancer
- 0.113 Receptor tyrosine kinase
- 0.098 Thyroid cancer
- 0.031 Personalized medicine
- 0.025 B-Raf
- 0.024 Erbitux
- 0.024 MAPK
- 0.024 Vectibix
- 0.022 Drug Discovery in Cancer Epigenetics
- More suggestions...